Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.53B |
| 3 |
Johnson & Johnson
JNJ
|
+$768M |
| 4 |
UnitedHealth
UNH
|
+$704M |
| 5 |
Tesla
TSLA
|
+$619M |
Top Sells
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$352M |
| 3 |
NVIDIA
NVDA
|
+$224M |
| 4 |
JPMorgan Chase
JPM
|
+$170M |
| 5 |
PPL Corp
PPL
|
+$168M |
Sector Composition
| 1 | Technology | 24.09% |
| 2 | Healthcare | 14.19% |
| 3 | Financials | 12.53% |
| 4 | Consumer Discretionary | 10.33% |
| 5 | Industrials | 6.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3726
Black Stone Minerals
BSM
$2.61B
| $34K | ﹤0.01% |
2,033
-44,455
| -96% | -$743K |
|
|
CAF
3727
Morgan Stanley China A Share Fund
CAF
$262M
| $34K | ﹤0.01% |
2,005
| – | – |
|
3728
Foghorn Therapeutics
FHTX
$291M
| $34K | ﹤0.01% |
5,397
+4,545
| +533% | +$28.6K |
|
3729
StealthGas
GASS
$272M
| $34K | ﹤0.01% |
12,500
| – | – |
|
3730
Nerdy
NRDY
$157M
| $34K | ﹤0.01% |
14,989
+12,691
| +552% | +$28.8K |
|
|
NREF
3731
NexPoint Real Estate Finance
NREF
$268M
| $34K | ﹤0.01% |
2,158
-2,583
| -54% | -$40.7K |
|
3732
Outlook Therapeutics
OTLK
$44.4M
| $34K | ﹤0.01% |
1,590
+1,339
| +533% | +$28.6K |
|
3733
Ouster
OUST
$1.64B
| $34K | ﹤0.01% |
3,896
+3,290
| +543% | +$28.7K |
|
3734
NeueHealth
NEUE
$60.8M
| $34K | ﹤0.01% |
648
+546
| +535% | +$28.6K |
|
|
AE
3735
DELISTED
Adams Resources & Energy Inc.
AE
| $34K | ﹤0.01% |
885
| – | – |
|
3736
Applied Digital
APLD
$4.45B
| $33K | ﹤0.01% |
18,140
+17,798
| +5,204% | +$32.4K |
|
3737
Arena Group
AREN
$291M
| $33K | ﹤0.01% |
3,118
+2,637
| +548% | +$27.9K |
|
3738
Empire Petroleum
EP
$138M
| $33K | ﹤0.01% |
2,715
+2,286
| +533% | +$27.8K |
|
3739
Immuneering
IMRX
$338M
| $33K | ﹤0.01% |
6,758
+2,168
| +47% | +$10.6K |
|
3740
Lineage Cell Therapeutics
LCTX
$276M
| $33K | ﹤0.01% |
28,109
+20,472
| +268% | +$24K |
|
3741
Northeast Community Bancorp
NECB
$272M
| $33K | ﹤0.01% |
2,182
+1,671
| +327% | +$25.3K |
|
3742
Relmada Therapeutics
RLMD
$53.4M
| $33K | ﹤0.01% |
9,427
+2,326
| +33% | +$8.14K |
|
3743
Rallybio
RLYB
$25.1M
| $33K | ﹤0.01% |
4,946
+4,270
| +632% | +$28.5K |
|
3744
Reservoir Media
RSVR
$511M
| $33K | ﹤0.01% |
5,492
+4,625
| +533% | +$27.8K |
|
3745
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$281M
| $33K | ﹤0.01% |
1,000
| – | – |
|
3746
UNIFI
UFI
$83M
| $33K | ﹤0.01% |
3,847
-97
| -2% | -$832 |
|
|
VXRT
3747
DELISTED
Vaxart
VXRT
| $33K | ﹤0.01% |
34,525
-621,592
| -95% | -$594K |
|
3748
Weyco Group
WEYS
$285M
| $33K | ﹤0.01% |
1,584
+1,334
| +534% | +$27.8K |
|
|
TGAN
3749
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $33K | ﹤0.01% |
6,109
+5,144
| +533% | +$27.8K |
|
|
TCRR
3750
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $33K | ﹤0.01% |
33,116
-445
| -1% | -$443 |
|